Takei et al. 27 reported activation of aryl hydrocarbon receptor signals in lung fibrosis and changes in immunological features, mainly presented as increased Tregs and suppression of inflammatory T cell subsets. The gene discussed is AHR; the disease is pulmonary fibrosis.